FDAClass IMay 20, 2020

Finasteride Plus 1.25 mg Capsule recall: Contamination

Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond…

Why was Finasteride Plus 1.25 mg Capsule recalled?

Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #02-27-2020:04@11, Exp. August 25, 2020.

Product
Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond…
Recalling firm
MasterPharm LLC
Quantity
7260 capsules
Distribution
Nationwide in the U.S.
Recall date
May 20, 2020
Classification
Class I
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls